These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 351394)

  • 21. The European Stroke Prevention Study (ESPS): results by arterial distribution.
    Sivenius J; Riekkinen PJ; Smets P; Laakso M; Lowenthal A
    Ann Neurol; 1991 Jun; 29(6):596-600. PubMed ID: 1892362
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preventing stroke.
    Br Med J; 1978 Aug; 2(6135):454-5. PubMed ID: 354745
    [No Abstract]   [Full Text] [Related]  

  • 23. Controversy in the interpretation of clinical trials.
    Armitage P
    Ann Neurol; 1979 Jun; 5(6):601-2. PubMed ID: 382980
    [No Abstract]   [Full Text] [Related]  

  • 24. Controversy in neurology: the Canadian study on TIA and aspirin. A critique of the Canadian TIA study. Reply.
    Barnett HJ; Gent M; Sackett DL; Taylor DW
    Ann Neurol; 1979 Jun; 5(6):599-601. PubMed ID: 382979
    [No Abstract]   [Full Text] [Related]  

  • 25. Clopidogrel With Aspirin in Acute Minor Stroke or Transient Ischemic Attack (CHANCE) Trial: One-Year Outcomes.
    Wang Y; Pan Y; Zhao X; Li H; Wang D; Johnston SC; Liu L; Meng X; Wang A; Wang C; Wang Y;
    Circulation; 2015 Jul; 132(1):40-6. PubMed ID: 25957224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Controversy on platelet-inhibiting drugs].
    Oelz O
    Schweiz Med Wochenschr; 1985 May; 115(20):703-7. PubMed ID: 3892659
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Study Group: "Evaluation of the efficacy of therapeutic treatments in cerebrovascular diseases"].
    Inzitari D; Fratiglioni L; Baldereschi M; Candelise L; Anzalone N; Bonatti ML; Prencipe M; Gandolfo C; Mamoli A; Rasura M
    Epidemiol Prev; 1990 Jun; 12(43):6-11. PubMed ID: 2149110
    [No Abstract]   [Full Text] [Related]  

  • 28. Stroke prevention.
    S Afr Med J; 1978 Aug; 54(8):300. PubMed ID: 715615
    [No Abstract]   [Full Text] [Related]  

  • 29. [Critical approach to a therapeutic trial in secondary prevention of cerebral ischemic accidents by antiaggregants].
    Guiraud-Chaumeil B
    Presse Med; 1983 Dec; 12(48):3045-8. PubMed ID: 6228912
    [No Abstract]   [Full Text] [Related]  

  • 30. Controversy in neurology: the Canadian study on TIA and aspirin. A critique of the Canadian TIA study.
    Kurtzke JF
    Ann Neurol; 1979 Jun; 5(6):597-9. PubMed ID: 382978
    [No Abstract]   [Full Text] [Related]  

  • 31. Proceedings: The effect of a platelet inhibiting drug (sulfinpyrazone) in the therapy of patients with transient ischemic attacks (Tia's) and minor strokes.
    Robertson JT; Dugdale M; Salky N; Robinson H
    Thromb Diath Haemorrh; 1975 Nov; 34(2):598. PubMed ID: 1105880
    [No Abstract]   [Full Text] [Related]  

  • 32. Placebo-controlled, double-blind clinical trials can impede medical progress.
    Ritter JM
    Lancet; 1980 May; 1(8178):1126-7. PubMed ID: 6103452
    [No Abstract]   [Full Text] [Related]  

  • 33. Sulfinpyrazone in the prevention of cardiac death after myocardial infarction. The Anturane Reinfarction Trial.
    Anturane Reinfarction Trial Research Group
    N Engl J Med; 1978 Feb; 298(6):289-95. PubMed ID: 340942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute Stroke or Transient Ischemic Attack Treated with Aspirin or Ticagrelor and Patient Outcomes (SOCRATES) trial: rationale and design.
    Johnston SC; Amarenco P; Albers GW; Denison H; Easton JD; Held P; Jonasson J; Minematsu K; Molina CA; Wong LK
    Int J Stroke; 2015 Dec; 10(8):1304-8. PubMed ID: 26311628
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Platelets, carotids, and coronaries. Critique on antithrombotic role of antiplatelet agents, exercise, and certain diets.
    Eichner ER
    Am J Med; 1984 Sep; 77(3):513-23. PubMed ID: 6383036
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aspirin-sulfinpyrazone in prophylaxis of deep venous thrombosis in total hip replacement.
    Sautter RD; Koch EL; Myers WO; Ray JR; Mazza JJ; Larson DE; Chen HM; Milbauer JP; Treuhaft PS; Plotka ED
    JAMA; 1983 Nov; 250(19):2649-54. PubMed ID: 6355542
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acetylsalicylic acid in the prevention of stroke in patients with reversible cerebral ischemic attacks. A Danish cooperative study.
    Sorensen PS; Pedersen H; Marquardsen J; Petersson H; Heltberg A; Simonsen N; Munck O; Andersen LA
    Stroke; 1983; 14(1):15-22. PubMed ID: 6337425
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transient ischemic attacks and the prevention of strokes.
    Mohr JP
    N Engl J Med; 1978 Jul; 299(2):93-5. PubMed ID: 661867
    [No Abstract]   [Full Text] [Related]  

  • 39. Aspirin and the prevention of stroke after transient ischaemic attack.
    Warlow C
    Monogr Atheroscler; 1986; 14():203-6. PubMed ID: 3526126
    [No Abstract]   [Full Text] [Related]  

  • 40. Guidelines for the management of transient ischemic attacks.
    Sandok BA; Furlan AJ; Whisnant JP; Sundt TM
    Mayo Clin Proc; 1978 Oct; 53(10):665-74. PubMed ID: 362079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.